Physician Profile

Faryal S. Mirza, M.D.

Assistant Professor of Medicine, Division of Endocrinology and Metabolism, UConn Health
UConn Musculoskeletal Institute

Dr. Mirza is an assistant professor of medicine in the Department of Medicine and Division of Endocrinology and Metabolism at UConn Health and the UConn School of Medicine. She specializes in the management of patients with osteoporosis, diabetes, thyroid and pituitary disorders and other women's health issues. She worked as a primary care physician for six years before pursuing a fellowship in hypertension at Harvard Medical School and Brigham and Women's Hospital in Boston, MA, followed by women's health and endocrinology and metabolism fellowships at the UConn School of Medicine. Her research interests include bone health and osteoporosis, gender biology and hypertension. Dr. Mirza's clinical experience and training provide her with special insight into women's health problems.

Office Locations:

UConn Health
Outpatient Pavilion, 2nd Floor East
263 Farmington Avenue
Farmington, CT 06030

Center for Osteoporosis
UConn Musculoskeletal Institute
UConn Health
263 Farmington Avenue
Farmington, CT 06030

Board Certifications:
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
Education and Training:
Medical SchoolAga Khan UniversityMedicine
Undergraduate SchoolBahauddin Zakariya UniversityScience
ResidencyGrant Hospital of ChicagoInternal Medicine
InternshipGrant Hospital of ChicagoInternal Medicine
ResidencyWestlake Community HospitalInternal Medicine
ResidencyWestlake Community HospitalChief Resident
FellowshipBrigham and Women's HospitalHypertension/Endocrinology
FellowshipHarvard Medical SchoolEndocrine Hypertension
FellowshipUniversity of Connecticut School of MedicineWomen's Health
FellowshipUniversity of Connecticut School of MedicineEndocrinology
Hospital Affiliation:
  • John Dempsey Hospital
Honors and Awards:
Name of Award/HonorAwarding Organization
Best Teacher AwardEndocrine fellows
"Chugai Award," Awarded to Present Research at the 4th Bone Research Seminar in Tokyo, Japan Chugai Pharmaceuticals
ASBMR “New Investigator Award” for “research presented at the annual ASBMR meeting in San Diego, California.American Society of Bone and Mineral Research
Fellow of American College of EndocrinologyAmerican College of Endocrinology
Junior Investigator AwardAmerican Society of Bone and Mineral Research
Physician-Scientist Career Enhancement Travel Award from the Center for Molecular Medicine, to Present Research at the Annual Meeting of the Endocrine SocietyUConn Health Center
Award for “Best Abstract in the Pathogenesis of Osteoporosis,” at the Annual ASBMR Meeting in Denver, ColoradoASBMR
Travel Award for Outstanding Research Presented at the Annual MeetingThe Endocrine Society
Clinical Fellows Travel Grant Award Genentech
Travel Award by Women in Endocrinology, for Research Presented at the Annual MeetingWomen in Endocrinology
Best Intern Award, Rush Presbyterian-Grant Hospital of Chicago Residency Program, Chicago, IllinoisGrant Hospital of Chicago
Academic Scholarship Award for Clinical Elective Clerkships at Alberta, Canada in Medical SchoolUniversity of Calgary
Merit Scholarship Board of Intermediate and Secondary Education, 1982-1987 Government of Pakistan
Gold Medal and National Talent Scholarship for First Class First position in Higher Secondary School Certification, 1978-1980 Government of Pakistan
Research Interests:

Bone health and osteoporosis, metabolic bone disease, gender biology, and physiological changes with menopause

Languages Other than English:
  • Punjabi
  • Urdu
Selected Publications:

Peer Reviewed Publications

Changes in bone sclerostin levels in mice after ovariectomy vary independently of changes in serum sclerostin levels. Jastrzebski, Sandra; Kalinowski, Judith; Stolina, Marina; Mirza, Faryal; Torreggiani, Elena; Kalajzic, Ivo; Won, Hee Yeon; Lee, Sun-Kyeong; Lorenzo, Joseph. (2013). Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 3, (28), 618-26.

Long-term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women. Chung, Y E; Lee, S H; Lee, S-Y; Kim, S-Y; Kim, H-H; Mirza, F S; Lee, S-K; Lorenzo, J A; Kim, G S; Koh, J-M. (2012). Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 4, (23), 1235-43.

Gonadal Hormones, Diseases and Emerging Therapeutics. Faryal S. Mirza, Liam Zakko, Pamela Taxel. (2012). Bone-Metabolic Functions and Modulators, 47-67.

Management of bone disease in patients undergoing hormonal therapy for breast cancer. Mirza, Faryal Sardar Ali. (2011). Endocrinology and metabolism clinics of North America, 3, (40), 549-62, viii.

Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. Mirza, Faryal S; Padhi, I Desmond; Raisz, Lawrence G; Lorenzo, Joseph A. (2010). The Journal of clinical endocrinology and metabolism, 4, (95), 1991-7.